Produktname:2-((1,3-Dioxo-1-phenylbutan-2-yl)diazenyl)-N-(quinoxalin-2-yl)benzenesulfonamide
IUPAC Name:2-[(1E)-2-(1,3-dioxo-1-phenylbutan-2-yl)diazen-1-yl]-N-(quinoxalin-2-yl)benzene-1-sulfonamide
- CAS:89010-65-1
- Molekulare Formel:C24H19N5O4S
- Reinheit:97%
- Katalognummer:CM222342
- Molekulargewicht:473.51
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:89010-65-1
- Molekulare Formel:C24H19N5O4S
- Schmelzpunkt:-
- SMILES-Code:O=S(C1=CC=CC=C1/N=N/C(C(C2=CC=CC=C2)=O)C(C)=O)(NC3=NC4=CC=CC=C4N=C3)=O
- Dichte:
- Katalognummer:CM222342
- Molekulargewicht:473.51
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.